The research, published in Frontiers in Radiology, enrolled 254 patients with acute chest pain and suspected coronary artery disease between February and April 2026. Patients were alternately assigned by examination date to two groups: 126 received virtual ECG-gated CCTA, which dispenses with surface electrodes altogether, and 128 received conventional true ECG-gated CCTA. The two groups were well matched in age, sex, body mass index, heart rate, and cardiovascular risk factors, and no patient received beta-blockers or nitroglycerin before scanning, ensuring that any differences in outcome stemmed from the gating strategy itself rather than from patient preparation.

The technology behind virtual ECG gating is elegantly counterintuitive. Instead of recording the patient’s actual electrical cardiac activity, the scanner generates a simulated, perfectly regular ECG signal based on a heart rate measured beforehand with a simple finger pulse oximeter, deliberately set slightly below the measured value to account for heart rate fluctuations during the scan. Data are then acquired over one complete cardiac cycle using a 256-row CT scanner with a 16-centimeter detector, wide enough to cover the entire heart in a single rotation. The simulated signal never represents the patient’s true ECG waveform and its R-R intervals are not temporally aligned with the real heartbeat; it serves purely as a temporal framework to trigger the scan and organize the reconstruction.

Two intelligent algorithms then do the heavy lifting. SmartPhase technology automatically selects, from among all available cardiac phases, the image with the least motion artifact based on image-based assessment rather than fixed phase assumptions. The chosen images are then processed with SnapShot Freeze, a coronary motion-correction algorithm that integrates data from adjacent cardiac phases, even across different heartbeats, to compensate for residual coronary motion. This combination allows the system to find the diagnostically best moment in the cardiac cycle without ever knowing where that moment truly fell in the patient’s real heartbeat.

The results were striking on the workflow side. Total examination time, measured from the patient lying on the table to the completion of image acquisition, dropped from an average of 4.15 minutes with true ECG gating to 2.83 minutes with virtual gating, a statistically significant reduction driven almost entirely by positioning time, which fell from 2.03 minutes to 0.89 minutes. Scan time itself did not differ significantly between groups, confirming that the time savings came from eliminating electrode attachment, signal adjustment, and signal stabilization. The researchers note that electrode placement can also require exposing private body areas, particularly in female patients, causing anxiety and discomfort that the virtual approach avoids altogether.

Image quality told an equally compelling story. Contrary to what might be expected from removing real-time cardiac synchronization, the virtual ECG-gated group actually showed lower image background noise and significantly higher signal-to-noise and contrast-to-noise ratios across the aortic root and all coronary artery segments studied. CT attenuation values, which reflect the contrast enhancement of the vessels, were comparable between groups. On the five-point subjective scale used by two blinded radiologists, scores for every major coronary artery and branch, from the left main artery to the ramus intermedius, were effectively identical between groups, with both achieving median scores of 5, indicating excellent image quality.

The researchers attribute the favorable quantitative parameters partly to protocol optimization: the noise index, a parameter that drives automatic tube current modulation, was set at 18 HU in the virtual group versus 20 HU in the conventional group, trading higher radiation output for lower image noise. Subjective evaluability, however, remained equivalent, suggesting the optimization did not distort the diagnostic appearance of the images. The authors caution that the improved objective metrics should be interpreted as the combined effect of gating strategy and protocol tuning rather than a benefit of virtual gating alone.

Diagnostic performance against invasive coronary angiography, the reference standard, provided the most clinically significant finding. Fifty-one patients underwent invasive angiography within 30 days of their CCTA, allowing vessel-level comparison across the four major coronary arteries of each patient, analyzed with cluster bootstrap resampling and mixed-effects models to account for multiple vessels per patient. Virtual ECG-gated CCTA achieved a diagnostic agreement rate of 92.00 percent with an area under the ROC curve of 0.89, compared with 85.58 percent and 0.82 for conventional gating, indicating that the electrode-free approach did not compromise, and numerically slightly exceeded, diagnostic accuracy.

The trade-off was radiation. The virtual approach delivered an effective dose of 3.58 millisieverts versus 3.18 millisieverts for true gating, an increase of roughly 13 percent, attributable to the wider acquisition window needed to capture the entire cardiac cycle. Still, the authors point out that this dose remains within the range of modern low-dose CCTA protocols and is comparable to or lower than figures reported for some third-generation dual-source systems. Prior work cited in the study suggests that narrowing the acquisition window could erase much of this dose difference, and the team advocates combining virtual gating with dose-reduction strategies such as low tube voltage, individualized windowing, and deep-learning-based reconstruction.

The clinical implications extend well beyond shaving a minute off the schedule. Reliable ECG signal acquisition can be difficult or impossible in patients with severe chest pain and poor cooperation, extensive chest burns or scars, cardiac tamponade, or those on life-support equipment, and conventional gating remains challenging in arrhythmias such as atrial fibrillation or in patients who cannot tolerate heart-rate-lowering drugs. By making CCTA independent of real-time ECG signals, virtual gating could expand access to rapid, accurate coronary imaging precisely in the emergency scenarios where it matters most. The authors acknowledge limitations, including the single-center design, modest sample size, date-based rather than truly random allocation, and the fact that invasive angiography was performed only in clinically indicated patients, but they conclude that virtual ECG-gated CCTA stands as a feasible, efficient strategy for selected patients with acute chest pain, particularly where speed and workflow simplicity are paramount.

Subject of Research: Comparison of virtual and true ECG-gated coronary CT angiography for diagnosing coronary artery disease in acute chest pain

Article Title: Comparison of virtual and true ECG-gated coronary CT angiography in patients with acute chest pain: a prospective cohort study

Article References: Wei, W., Lu, L., Wu, Y., Fang, Q., Li, Y., Zhou, J., Li, R., Han, D., Ke, T., & Zhao, W. (2026). Comparison of virtual and true ECG-gated coronary CT angiography in patients with acute chest pain: a prospective cohort study. Frontiers in Radiology, 6, Article 1893538. https://doi.org/10.3389/fradi.2026.1893538

Image Credits: AI Generated

DOI: 10.3389/fradi.2026.1893538

Keywords: coronary CT angiography, virtual ECG gating, acute chest pain, coronary artery disease, image quality, radiation dose, emergency radiology, invasive coronary angiography, ECG-independent imaging, motion correction, diagnostic accuracy, wide-detector CT

The research, published in BMC Medical Imaging by a team at Ardabil University of Medical Sciences in Iran, directly compared coronary computed tomography angiography, or CCTA, with invasive coronary angiography in 155 patients suspected of having coronary artery disease. Every patient in the study underwent both tests, allowing the investigators to measure how well the non-invasive scan performed against the gold standard. The results were striking in one direction and sobering in another: CCTA detected diseased arteries with a sensitivity of 96 percent, meaning it flagged nearly every patient who truly had significant coronary stenosis, but its specificity was just 33.3 percent, indicating that many positive findings did not hold up under invasive confirmation.

Those two numbers tell a story that cardiologists know well. Sensitivity measures how reliably a test finds disease when disease is present; specificity measures how reliably it clears patients who are actually healthy. A test with very high sensitivity and modest specificity is an excellent rule-out tool—it rarely misses a dangerous blockage—but it risks overcalling disease, which can funnel worried patients toward more invasive testing. In this cohort, CCTA achieved a positive predictive value of 85.7 percent, meaning that when the scan called a vessel diseased, it was right about six times out of seven. Its negative predictive value was 66.7 percent, and its overall accuracy came to 83.9 percent.

The study’s design was straightforward but demanding. The 155 participants, whose average age was 57.3 years and roughly two-thirds of whom were men, each underwent both imaging procedures. The researchers graded coronary stenosis—the narrowing of the arteries by plaque—into three categories: mild narrowing of 1 to 49 percent of the vessel’s diameter, moderate narrowing of 50 to 69 percent, and severe narrowing of 70 percent or more. Invasive coronary angiography served as the reference standard against which every CCTA reading was judged. This head-to-head design matters because diagnostic performance is never absolute; it depends on the population being tested, the prevalence of disease, and the threshold used to call a vessel abnormal.

One of the study’s most clinically useful findings emerged when the researchers broke the results down by individual coronary artery. The left anterior descending artery, the vessel most famously implicated in serious heart attacks, showed the highest vessel-based sensitivity at 87 percent. The left circumflex artery, which wraps around the side of the heart, proved the hardest to assess, with sensitivity dropping to 60 percent. That anatomical variation is not surprising to imaging specialists: the circumflex is smaller, more variable in its course, and often partially obscured in tomographic images, while the left anterior descending is larger and runs along the front of the heart where CT resolution is strongest.

The severity of the blockage also shaped how well the scan performed. CCTA correctly identified every case of moderate stenosis in the cohort and detected 69 percent of severe stenoses. That pattern may seem counterintuitive—surely the worst blockages should be the easiest to spot—but it reflects the physics and physiology of CT imaging. Severe, calcified plaques can cause blooming artifacts on CT, where dense calcium appears larger than it is and can obscure the true channel of blood flow. Moderate lesions, by contrast, often present a clearer target. The finding underscores that a clean CCTA report does not automatically exclude high-grade disease in every vessel, particularly in patients whose symptoms remain concerning.

Coronary artery disease remains the leading cause of death and disability worldwide, which is why the stakes of diagnostic imaging are so high. Narrowed coronary arteries starve the heart muscle of oxygen, producing angina and, when a plaque ruptures and a clot forms, myocardial infarction. The traditional pathway to diagnosis—injecting contrast through a catheter threaded from the wrist or groin into the coronary arteries—carries small but real risks of bleeding, vessel damage, arrhythmia, and radiation exposure, along with the cost and anxiety of an invasive procedure. A reliable non-invasive alternative that can safely rule out significant disease would spare countless patients a trip to the catheterization laboratory.

CCTA offers exactly that promise. The technique uses rapid, ECG-gated CT scanning synchronized to the heartbeat, with intravenous contrast opacifying the coronary lumen. Modern scanners reconstruct the moving coronary tree in three dimensions, allowing radiologists to inspect plaque burden, vessel narrowing, and even plaque composition from outside the body. Its high negative predictive value in broader populations—often above 95 percent in large multicenter trials—has made it a cornerstone of chest pain triage in emergency departments, where its main job is to send low-risk patients home quickly. The Ardabil study’s 96 percent sensitivity is consistent with that rule-out role, even though its specificity lagged in this particular high-risk group.

Why was specificity so low here? The answer likely lies in the study population and the reference standard itself. In a cohort of patients already suspected of coronary disease and referred for both tests, disease prevalence is high, which statistically depresses specificity and positive predictive value. Moreover, invasive angiography and CCTA do not measure exactly the same thing: invasive angiography shows the contrast-filled lumen of the vessel, while CCTA visualizes the vessel wall and the plaque within it. A vessel remodeled outward by plaque may look abnormal on CT but show a preserved lumen on catheterization, and vice versa. Calcification, motion artifact, and heart rate control during scanning can all degrade CT images and inflate false positives. The authors themselves note that these findings support CCTA as a useful non-invasive diagnostic tool while invasive angiography remains the reference standard for confirming stenosis.

The practical takeaway for patients and clinicians is a layered strategy rather than a replacement. CCTA, with its near-perfect sensitivity, functions best as the gatekeeper: a normal scan can reassure patients and avoid unnecessary invasive procedures, while an abnormal scan directs them toward confirmatory testing, functional assessment, or treatment. Invasive coronary angiography retains its decisive role not only in confirming anatomy but in enabling treatment—stents can be placed and pressure measurements taken during the same procedure. As scanner technology improves, with photon-counting detectors, better motion correction, and computational fluid dynamics that compute fractional flow reserve from CT images alone, the gap between the two techniques may continue to narrow. For now, this study of 155 patients offers a clear-eyed measurement of where the technology stands: superb at finding disease, imperfect at excluding it, and best used as the first, non-invasive step in a careful diagnostic sequence.

Subject of Research: Comparative diagnostic accuracy of coronary CT angiography versus invasive coronary angiography for suspected coronary artery disease

Article Title: Comparative diagnostic performance of coronary CT angiography and invasive coronary angiography in patients with suspected coronary artery disease

Article References: Farzollahzadeh, A., Shahsavari, M.-J., Mashoufi, M., Bagali, F. M., & Refahi, S. (2026). Comparative diagnostic performance of coronary CT angiography and invasive coronary angiography in patients with suspected coronary artery disease. BMC Medical Imaging, 26(1), Article 479. https://doi.org/10.1186/s12880-026-02785-3

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02785-3

Keywords: coronary artery disease, coronary CT angiography, invasive coronary angiography, diagnostic accuracy, coronary stenosis, sensitivity, specificity, medical imaging, cardiology, BMC Medical Imaging, Comparative, diagnostic

The research, led by Yuting Wen, Wanjiang Li, Xuelin Pan, Hangjia Hu and corresponding author Zhenlin Li of the Department of Radiology, with Xiaodi Zhang of Philips Healthcare, set out to answer a deceptively simple question: at which virtual monoenergetic energy level does spectral CT angiography best quantify coronary stenosis in patients whose arteries are burdened with calcified plaque? The team prospectively enrolled 42 patients with clinical suspicion of coronary atherosclerosis. Each participant underwent coronary CT angiography using a dual-layer spectral CT scanner and then completed invasive coronary angiography within four weeks, allowing the researchers to compare every imaging reconstruction against the reference standard in the same patients.

Dual-layer spectral CT, sometimes called detector-based spectral imaging, works differently from a conventional scanner. Instead of a single detector registering a blended X-ray spectrum, it stacks two detector layers that simultaneously record low- and high-energy photons from every projection. Software can then synthesize virtual monoenergetic images, or VMIs, which simulate how the anatomy would look if it were imaged with X-rays of a single, pure energy level measured in kiloelectron volts, or keV. At low energies around 40 keV, iodine contrast in the vessel lumen glows brightly, but beam hardening and noise increase. At high energies approaching 190 keV, calcium’s blooming shrinks and streak artifacts fade, but the iodine signal weakens and images can become washed out. Somewhere in between lies a sweet spot, and finding it for calcified coronary arteries was the study’s central goal.

In this trial, the researchers reconstructed conventional 120 kVp images along with virtual monoenergetic images spanning 40 to 190 keV at 30 keV intervals, all at the optimal cardiac phase on a dedicated post-processing workstation. They then compared image quality and vascular stenosis measurements across the multiple reconstruction groups, both between groups and within the same patients. Objective indicators such as signal-to-noise ratio and contrast-to-noise ratio were analyzed with one-way analysis of variance, followed by Tukey’s Honestly Significant Difference test for pairwise comparisons. Subjective image quality scores, assigned by radiologists assessing diagnostic confidence, artifacts and vascular visualization, were evaluated with the Friedman test. Two independent radiologists graded the images, and their inter-observer agreement was measured with Cohen’s weighted kappa, where values of 0.75 or above indicate excellent agreement.

The headline result is striking. Bland-Altman analysis, a statistical technique for quantifying agreement between two measurement methods, showed no significant difference between stenosis rates measured on 100 keV virtual monoenergetic images and those obtained from invasive coronary angiography, with a P value of 0.726. The bias rate of the 100 keV reconstructions was only approximately 0.1 percent, meaning the noninvasive measurements deviated from the catheter-based gold standard by a vanishingly small margin on average. By contrast, conventional 120 kVp images carried a bias rate of 10.3 percent, a discrepancy large enough to change clinical decisions in borderline cases. The improvement achieved by the 100 keV setting averaged 10.2 percentage points, a difference the authors report as statistically significant at P less than 0.01.

Image quality metrics told a consistent story. Significant differences in image quality were observed between the conventional 120 kVp images and every virtual monoenergetic group, all with P values below 0.01. Among the spectral reconstructions, the 100 keV images earned the highest subjective scores, reaching 4.81 plus or minus 0.40 on the rating scale for diagnostic confidence, image artifacts and vascular visualization, again with P less than 0.01. In practical terms, radiologists found that vessels surrounded by calcium were easier to trace, artifacts were less distracting, and they felt more confident rendering a diagnosis from the 100 keV series than from any alternative. Cohen’s weighted kappa values between the two observers all exceeded 0.75, confirming that this confidence was not the product of one reader’s idiosyncratic eye but a reproducible property of the images themselves.

The physics behind the result is worth unpacking. Calcified plaque and iodinated contrast differ in how their X-ray attenuation changes with photon energy. Calcium’s attenuation falls steeply as energy rises, so at 100 keV the bright halo around a calcified nodule contracts considerably, letting the contrast-opacified lumen behind it show through. Iodine, meanwhile, retains enough attenuation at 100 keV to keep the arterial lumen clearly delineated, even though its signal is weaker than at 40 or 70 keV. The 100 keV level therefore balances two competing demands: suppressing the calcium blooming that inflates apparent stenosis, while preserving the iodine contrast that defines the vessel wall and lumen. Lower energy reconstructions, despite their luminous iodine signal, amplify the very artifacts that distort stenosis grading in calcified segments, while higher energies sacrifice too much luminal contrast to remain diagnostically reliable.

The clinical implications are considerable. Invasive coronary angiography remains the reference standard for defining coronary stenosis, but it involves arterial catheterization, iodine loads, radiation exposure, procedural risk and cost, and it is not justified as a screening tool. Coronary CT angiography is noninvasive, fast and widely available, yet calcified plaques, which are common in older patients and in those with diabetes or chronic kidney disease, have long limited its accuracy, sometimes forcing patients into the catheterization laboratory on the basis of overestimated narrowing. If spectral CT scanners can routinely reconstruct 100 keV images that track invasive measurements within a fraction of a percent on average, the noninvasive test becomes substantially more trustworthy for the large population of patients with calcified coronary disease, potentially sparing some from unnecessary invasive procedures while ensuring that truly significant stenoses are not underestimated.

The study does have boundaries worth noting. Forty-two patients is a modest sample, and the cohort consisted of individuals with clinical suspicion of coronary atherosclerosis at a single center, so larger multicenter validation will be needed before the 100 keV recommendation becomes universal practice. The analysis focused on stenosis quantification in calcified plaques rather than on plaque characterization, ischemia prediction or outcomes, and the scanners, reconstruction software and reader expertise at West China Hospital may not translate identically to every imaging environment. The work was supported by the 1.3.5 project for disciplines of excellence at West China Hospital, Sichuan University, and the authors declare no competing interests. The article was published open access under a Creative Commons license, received by the journal on 15 July 2026, accepted on 28 August 2026 and published on 11 September 2026.

Even so, the findings land at a moment when spectral CT is spreading rapidly through hospital radiology departments, and they offer an unusually concrete, actionable takeaway: when quantifying coronary stenosis in the presence of calcified plaque, reconstruct and read the 100 keV virtual monoenergetic images. The study demonstrates that a single, well-chosen energy level can convert spectral CT from an imaging novelty into a measurement instrument whose numbers align with the catheter lab. For patients, that could mean fewer ambiguous reports and fewer unnecessary invasive procedures. For radiologists and cardiologists, it supplies an evidence-based default setting for one of coronary imaging’s most stubborn problems. As dual-layer detectors become standard equipment, the humble kiloelectron volt dial, tuned to 100 keV, may quietly become one of the most consequential settings in cardiac imaging.

Subject of Research: Determining the optimal virtual monoenergetic energy level of dual-layer spectral CT angiography for quantifying coronary stenosis in patients with calcified coronary plaques.

Article Title: Optimal virtual monoenergetic energy level of dual-layer spectral CT angiography for coronary stenosis quantification in patients with calcified coronary plaques: a prospective study

Article References: Wen, Y., Li, W., Pan, X., Hu, H., Zhang, X., & Li, Z. (2026). Optimal virtual monoenergetic energy level of dual-layer spectral CT angiography for coronary stenosis quantification in patients with calcified coronary plaques: a prospective study. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02746-w

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02746-w

Keywords: spectral CT, coronary CT angiography, calcified plaque, coronary stenosis, virtual monoenergetic images, dual-layer detector, invasive coronary angiography, image quality, blooming artifact, BMC Medical Imaging, radiology, atherosclerosis